ConductScience.org, home

Paper7908520

Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate.

Hoffman GS and 5 others. Arthritis Rheum, 1994. Cited by 272 papers, by iCite.

Cite this record

ConductScience Library. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Papers, record 7908520. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7908520

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate.
PubMed
Journal
Arthritis Rheum
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
272
iCite
Relative citation ratio, by iCite
9.5
iCite
Revised in PubMed
2019-07-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoffman GSG S
2Leavitt RYR Y
3Kerr GSG S
4Rottem MM
5Sneller MCM C
6Fauci ASA S

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucocorticoidsMajor topic
MethotrexateMajor topic
Takayasu ArteritisMajor topic
Adolescent
Adult
Drug Administration Schedule
Drug Resistance
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Pilot Projects
Recurrence
Remission Induction

Source PubMed

Download CSV of topics

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 272 citations.

PMIDTitleJournalYearIn PapersSource
42770035Takayasu Arteritis in a 15-Year-Old Male Presenting with Constitutional Symptoms and Upper Limb Pulse Deficit: A Case Report a Resource-Limited Settings.Int Med Case Rep J2026https://conductscience.org/library/papers/42770035PubMed
42081084Large Vessel Vasculitis: Recent Advances in Pathophysiology and Targeted Therapies.Drugs2026https://conductscience.org/library/papers/42081084PubMed
41587271Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.Circulation2026https://conductscience.org/library/papers/41587271PubMed
40535368A 50-Year Delay in the Diagnosis of Takayasu Arteritis: Clinical Presentation and Therapeutic Insights.Cureus2025https://conductscience.org/library/papers/40535368PubMed
39377926Cerebrovascular implications of takayasu arteritis: a review.Neuroradiology2025https://conductscience.org/library/papers/39377926PubMed
39319180Severe aortic valve regurgitation in patient with Takayasu arteritis: a case report.Eur Heart J Case Rep2024https://conductscience.org/library/papers/39319180PubMed
39077599Clinical Features of Aortitis with Gastrointestinal Involvement.Rev Cardiovasc Med2022https://conductscience.org/library/papers/39077599PubMed
38933629Unravelling a Triad: A Rare Case of Takayasu Arteritis, Hashimoto's Thyroiditis, and Psoriasis in a Young Female With Heart Failure.Cureus2024https://conductscience.org/library/papers/38933629PubMed
38158224Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update.Stroke Vasc Neurol2023https://conductscience.org/library/papers/38158224PubMed
38125643Advances and challenges in management of large vessel vasculitis.Rheumatol Immunol Res2023https://conductscience.org/library/papers/38125643PubMed
37321669Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.RMD Open2023https://conductscience.org/library/papers/37321669PubMed
36045929Advances in Takayasu arteritis: An Asia Pacific perspective.Front Med (Lausanne)2022https://conductscience.org/library/papers/36045929PubMed
35601856Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?Saudi J Ophthalmol2021https://conductscience.org/library/papers/35601856PubMed
35096902Novel Therapies in Takayasu Arteritis.Front Med (Lausanne)2021https://conductscience.org/library/papers/35096902PubMed
34685390Takayasu's Arteritis Diagnosed in an Adolescent Patient with Crohn's Disease: Management of Biologicals.Life (Basel)2021https://conductscience.org/library/papers/34685390PubMed
34671607Single-Cell RNA Sequencing Revealed CD14+ Monocytes Increased in Patients With Takayasu's Arteritis Requiring Surgical Management.Front Cell Dev Biol2021https://conductscience.org/library/papers/34671607PubMed
34435143Non-specific aortoarteritis (NSAA) in children: a prospective observational study.BMJ Paediatr Open2021https://conductscience.org/library/papers/34435143PubMed
34317327Takayasu Arteritis With Extensive Cardiovascular, Neurovascular, and Mesenteric Involvement.JACC Case Rep2020https://conductscience.org/library/papers/34317327PubMed
33932173Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis-a systematic review and meta-analysis.Clin Rheumatol2021https://conductscience.org/library/papers/33932173PubMed
33646393A hypertensive girl with failure to thrive accompanied by gastrointestinal symptoms: Answers.Pediatr Nephrol2021https://conductscience.org/library/papers/33646393PubMed

See all 86 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7908520

GET https://conductscience.org/api/papers/v1/7908520/cited_by?page=2